$6.10
+0 (+0%)
At Close: Dec 10, 2025
BioSig Submits Application to Systems for Award Management (SAM) with U.S. Government
05:15pm, Friday, 10'th Jul 2020
Westport, CT, July 10, 2020 -- BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal.
ViralClear, supported by AMRI, is undertaking research to investigate the potential of merimepodib to fight SARS-CoV-2.
Antivirals Rather Than Vaccines For COVID-19 (NASDAQ:BCRX)
12:26pm, Tuesday, 07'th Jul 2020
The likelihood appears slim of an adequately effective and widely available vaccine being in commercial use before H2 2021.
BioSig Technologies Inc. Appoints Tony Zook to the Board of Directors
01:15pm, Wednesday, 01'st Jul 2020
Westport, CT, July 01, 2020 -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical.
BioSig Technologies, Inc Closes $17.5 Million Common Stock Offering
12:18pm, Monday, 29'th Jun 2020
The gross proceeds to the Company from this offering were $17.5 million, before deducting placement agent fees and other offering expenses payable by the Company. The Company intends to use the net p
BIOSIG TECHNOLOGIES, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | MarketScreener
09:23pm, Friday, 26'th Jun 2020BioSig Technologies Sees Unusually High Options Volume (NASDAQ:BSGM)
01:30am, Friday, 26'th Jun 2020
BioSig Technologies Inc (NASDAQ:BSGM) was the recipient of some unusual options trading activity on Wednesday. Traders bought 949 put options on the company. This is an increase of 1,296% compared to
Why BioSig Technologies Is Plunging Today | The Motley Fool
04:57pm, Wednesday, 24'th Jun 2020
The company announced a common stock offering.
Dow Keeps Tumbling, Nasdaq Set to Snap Win Streak - Schaeffer's Investment Research
04:14pm, Wednesday, 24'th Jun 2020
Stocks are extending their morning losses as the Nasdaq looks to snap its eight-day winning streak while the VIX pivots higher
BioSig Technologies, Inc. Announces $17.5 Million Common Stock Only Registered Direct Offering
01:20pm, Wednesday, 24'th Jun 2020
The gross proceeds to the Company from this offering are expected to be $17.5 million, before deducting placement agent fees and other offering expenses payable by the Company. The Company intends to
Los índices de Estados Unidos cierran a la baja; el Dow Jones Industrial Average cae un 2,72%
12:00am, Wednesday, 24'th Jun 2020
Los índices de Estados Unidos cierran a la baja; el Dow Jones Industrial Average cae un 2,72%
ViralClear Partners with Catalent on Potential Treatment for COVID-19
06:30pm, Monday, 22'nd Jun 2020
Westport, CT, June 22, 2020 -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that.
ViralClear Opens Enrollment with First Patient Dosing in Phase II Human Trial of Anti-Viral MMPD Oral Solution for Treatment of COVID-19
11:55am, Wednesday, 17'th Jun 2020
Westport, CT, June 17, 2020 -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that.
Start Time: 11:00 End Time: 11:47 BioSig Technologies, Inc. (NASDAQ:BSGM) Special Call June 09, 2020, 11:00 AM ET Company Participants Ken Londoner - Chairman a
Sign In
Buy BSGM